
Omaxe Subsidiary Secures RERA Registration for Commercial Project in Uttar Pradesh
Omaxe Limited's Wholly-Owned Subsidiary, Mis Omaxe Garv Buildtech Private Limited, has received a Real Estate Regulatory Authority (RERA) Registration Certificate for one of its upcoming projects. The registration pertains to a commercial development and is governed by the Uttar Pradesh Real Estate Regulatory Authority (U.P. RERA).The project, named Commercial-3 Block-4, was launched on 12-08-2026. This crucial approval enables the subsidiary to proceed with the sale, transfer, and advertising of the development. The registration is valid until 17-12-2030, subject to extension by the relevant Authority.
The project is categorized as commercial and caters to both domestic and international markets. It is located at Commercial-3 Block-4 on Khasra Nos. 635(P), 2161(P), 2223(P) & 2224(P) in Tehsil-Sarojini Nagar, District-Lucknow, UP.
Key details regarding the project and regulatory status are presented below:
| Particulars | Details |
|---|---|
| Project Name | Commercial-3 Block-4 |
| Category of Project | Commercial |
| Market Coverage | Domestic & International |
| Regulatory Authority | Uttar Pradesh Real Estate Regulatory Authority (U.P. RERA) |
| Registration Number | UPRERAPRJ364597/08/2026 |
| Launch Date | 12-08-2026 |
| Approval Validity | Valid till 17-12-2030 |
This RERA registration signifies compliance with real estate regulations and is expected to significantly impact the consolidated financial performance of Omaxe Limited. The approval enhances credibility, ensures timely delivery, and fosters trust among buyers by guaranteeing legal protection for the project.
OMAXE Stock Price Movement
Omaxe Limited shares slipped on Tuesday, closing down 2.34% to settle at ₹83.03 after trading heavily throughout the session. The stock saw a strong volume of 243,610 shares traded during the market day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.